R

Ranbaxy Laboratories Ltd (Merged)

RANBAXY NSE

Technical Indicators

Key Insights

Strengths

1
  • Debtor days have improved from 74.3 to 57.0 days.

Weaknesses

3
  • Stock is trading at 9.99 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 9.16% over last 3 years.

Growth Rate

Revenue Growth
0.00% →
Net Income Growth
-157.00% →
Cash Flow Change
-
ROE
-18.00% ↘
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Results

  Dec 2011Mar 2012Jun 2012Sep 2012Dec 2012Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014
Depreciation 16880780808001339200097
EPS in Rs -70.6829.54-13.8817.86-11.642.97-12.39-10.73-3.75-1.74-4.3911.27-24.23
Expenses 3,0282,6902,9982,3722,6582,3172,5112,6022,6242,4132,2862,5552,506
Interest 9119165-1613653159111121114142137147
Net Profit -2,9801,248-584757-489130-523-453-162-79-189477-1,024
OPM % 21%29%8%12%2%6%5%7%9%2%5%22%4%
Operating Profit 7981,0912613365315512319927054130705113
Other Income -3,443405-530459-289144-451-346-11989-181-5-5
PBT -2,9031,398-512811-453167-487-391-6030-192563-135
Sales 3,8263,7813,2592,7082,7112,4722,6342,8022,8942,4672,4163,2602,619
Tax % 3%10%13%7%8%21%6%15%163%371%-3%15%656%

Profit & Loss

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014 15mTTM
Depreciation 10914917228226837239432047697
Div. Payout % 121%62%41%0%0%6%0%0%0%—
EPS in Rs —13.6920.76-22.637.0535.55-68.7121.82-25.61-19.09
Expenses 5,0225,2766,1438,7566,9247,8068,86110,64712,2819,760
Interest 671041412067161306304557540
Net Profit 264515787-9433071,509-2,890932-1,087-815
OPM % 2%13%8%-20%8%12%14%14%7%9%
Operating Profit 112781540-1,4605911,0701,4551,8059771,002
Other Income 2591237714487581,463-3,44164-686-100
PBT 194651999-1,5001,0102,100-2,6861,245-742265
Sales 5,1346,0576,6847,2967,5158,87610,31512,45213,25910,762
Tax % -36%21%21%-38%69%28%7%24%45%—

Balance Sheet

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014
Borrowings 2,0043,9564,1424,2853,6304,3354,4914,9016,598
CWIP 560358357471623382227208303
Equity Capital 186186187210210211211211212
Fixed Assets 2,0593,8954,2054,4904,4904,5484,8305,0085,081
Investments 1736240543541498987972
Other Assets 3,3334,1434,4767,7336,4838,71610,55711,1578,522
Other Liabilities 1,5171,8912,3334,6564,1654,2058,3527,4664,077
Reserves 2,2612,4002,6174,0864,1335,3942,6583,8733,091
Total Assets 5,9698,4329,27813,23712,13714,14415,71216,45213,978
Total Liabilities 5,9698,4329,27813,23712,13714,14415,71216,45213,978

Cash Flow

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014
CFO/OP 2135921511420259105-323
Financing 7461,513-392,676-522791-1,2182371,016
Investing -838-1,993-841-1,77654-2,1961,781-1,8711,958
Operating 2045291,023-152-1621,5396391,582-3,562
Free Cash Flow -704109587-586-6531,1121901,117-4,335
Net Cash Flow 11249143749-6311341,202-52-588

Ratios

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014
Cash Conversion Cycle 178213186168137102236159154
Days Payable 127130116133171230156146111
Debtor Days 8195826789661066057
Inventory Days 224248220234219266286246209
ROCE % —14%16%-18%12%21%15%21%7%
Working Capital Days 113124104-2432531-1856

Documents

Frequently Asked Questions about Ranbaxy Laboratories Ltd (Merged)

What does Ranbaxy Laboratories Ltd (Merged) do?
Ranbaxy Laboratories Limited,Incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceutical
Where is Ranbaxy Laboratories Ltd (Merged) (RANBAXY) listed?
Ranbaxy Laboratories Ltd (Merged) is listed on the Indian stock exchanges. It is listed on NSE: RANBAXY. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Ranbaxy Laboratories Ltd (Merged) belong to?
Ranbaxy Laboratories Ltd (Merged) operates in the Healthcare sector. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Ranbaxy Laboratories Ltd (Merged) on Tapetide?
On Tapetide, you can view Ranbaxy Laboratories Ltd (Merged)'s live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Ranbaxy Laboratories Limited,Incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceutical

Website ranbaxy.com
Face Value ₹ 5